Takeda Pharmaceutical Says Phase 3 Leukemia Drug Trial Meets Main Endpoint - Marketscreener.com

Takeda Pharmaceutical Says Phase 3 Leukemia Drug Trial Meets Main Endpoint  Marketscreener.com